North Estonia Medical Centre

From Beacon
Revision as of 17:14, 4 November 2022 by Lucas (talk | contribs) (→‎Trials)

The North Estonia Medical Centre is one of the top healthcare providers in the country. The Medical Center’s statutes states their goal is "to provide high-quality, specialized medical care and ambulance services, to be the learning base of training that precedes and follows the acquiring of health care professionals’ qualifications and does healthcare-related study and research work."

Trials

Study of AGEN2034 in Advanced Tumors and Cervical Cancer

Summary: This is a 2-part trial: a Phase 1, open-label, dose-escalation study in subjects with metastatic or locally advanced solid tumors, with a consecutive Phase 2 expansion to evaluate efficacy in subjects with recurrent, unresectable, or metastatic (advanced) cervical cancer that has progressed after a platinum-based treatment regimen.

Sponsor, manager, or home institution: Agenus Inc.

Intervention/Treatment: Drug: AGEN2034

Number of patients: 211 participants

Beginning Date: April 7, 2017

Last Update: November 3, 2022

Recruitment Status: Completed.

Cancer areas of interest: Advanced Cancer and Cervical Cancer

Experts

Learning Resources

Novel Therapies and Diagnostic Methods

Cancer-related Patient Associations